Rituximab-induced interstitial lung disease: five case reports

Rituximab (RTX), a mouse/human chimeric anti-CD20 IgG1 monoclonal antibody has been effectively used as a single agent or in combination with chemotherapy regimen to treat lymphoma since 1997. In addition, it has been used to treat idiopathic thrombocytopenic purpura, systemic lupus erythematous, rh...

Descripción completa

Detalles Bibliográficos
Autores principales: Naqibullah, Matiuallah, Shaker, Saher B., Bach, Karen S., Bendstrup, Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Co-Action Publishing 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629765/
https://www.ncbi.nlm.nih.gov/pubmed/26557260
http://dx.doi.org/10.3402/ecrj.v2.27178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629765/
https://www.ncbi.nlm.nih.gov/pubmed/26557260
http://dx.doi.org/10.3402/ecrj.v2.27178

Ejemplares similares